← Leaderboards
Gypsyamber D'souza
Johns Hopkins University
$25,879,984
Attributed
$47,976,296
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$58,519,614 · 7
By mechanism
U01$32,757,609 · 1
UM1$10,543,318 · 1
R35$8,435,580 · 1
R01$4,266,345 · 1
P50$1,819,399 · 1
R56$697,363 · 2
Top collaborators
- Stephen John Gange16 shared
- Elizabeth T Golub16 shared
- Lisa P Jacobson3 shared
- Carole Fakhry1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Maura L Gillison$5,649,784
- Eric L Nuermberger$20,859,483
- Richard Bruce Roden$11,133,737
- Justin C McArthur$21,339,205
- Lisa P Jacobson$80,226,469
Others in their field
Top investigators on “Epidemiology”
- David Heimbrook · Leidos Biomedical Research, Inc.$390,770,069
- George R Seage · Abt Associates, Inc.$299,251,523
- Jeffrey P Krischer · University Of South Florida$264,076,260
- Barbara Driver · Westat, Inc.$221,167,491
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,739,528
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
EpidemiologyParticipantRisk FactorsCohort StudiesHiv InfectionsVisitProtocols DocumentationMalignant NeoplasmsWomanBiologicalComorbidityMalignant Oropharynx NeoplasmHuman PapillomavirusResearch DesignOropharyngealOralIncidenceInfectionBehavioralHigh RiskResearch PersonnelPublicationsCohortHuman Papillomavirus 16
Grant awards (40)
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study$4,836,388
U01 · FY2025 · HL
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study$4,559,316
U01 · FY2024 · HL
MWCCS NIAID Data Ecosystem Supplement$818,355
U01 · FY2024 · HL
Earlier detection of HPV-related oropharynx cancer in people living with and without HIV$515,812
R56 · FY2024 · DE
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study$4,459,316
U01 · FY2023 · HL
Impacting the oral HPV continuum: prevention, screening, and early detection$1,047,916
R35 · FY2023 · DE · contact PI
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study$4,534,086
U01 · FY2022 · HL
Impacting the oral HPV continuum: prevention, screening, and early detection$1,047,123
R35 · FY2022 · DE · contact PI
2022 CCS Oral Microbiome and Pulmonary Function Supplement$15,411
U01 · FY2022 · HL
Sex differences in the role of multi-omicsin HIV-associated carotid artery atherosclerosis$11,716
U01 · FY2022 · HL
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study$4,586,672
U01 · FY2021 · HL
Impacting the oral HPV continuum: prevention, screening, and early detection$1,057,699
R35 · FY2021 · DE · contact PI
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study$16,344
U01 · FY2021 · HL
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study$4,530,685
U01 · FY2020 · HL
Impacting the oral HPV continuum: prevention, screening, and early detection$1,057,699
R35 · FY2020 · DE · contact PI
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study$130,469
U01 · FY2020 · HL
MWCCS Admin. Supplement: Association of Biomarkers with HIV and Clinical Outcomes$46,066
U01 · FY2020 · HL
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study$41,464
U01 · FY2020 · HL
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study$3,272,000
U01 · FY2019 · HL
Impacting the oral HPV continuum: prevention, screening, and early detection$1,057,699
R35 · FY2019 · DE · contact PI
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study (NHLBI Supplement)$821,012
U01 · FY2019 · HL
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study (Other IC Supplement)$78,309
U01 · FY2019 · HL
Center/Coordination, Analysis and Management/MACS$3,407,654
UM1 · FY2018 · AI · contact PI
Impacting the oral HPV continuum: prevention, screening, and early detection$1,057,699
R35 · FY2018 · DE · contact PI
Center/Coordination, Analysis and Management/MACS$3,662,509
UM1 · FY2017 · AI · contact PI
Impacting the oral HPV continuum: prevention, screening, and early detection$1,056,353
R35 · FY2017 · DE · contact PI
Center/Coordination, Analysis and Management/MACS$3,473,155
UM1 · FY2016 · AI · contact PI
Impacting the oral HPV continuum: prevention, screening, and early detection$1,053,392
R35 · FY2016 · DE · contact PI
Project 5$336,872
P50 · FY2016 · DE · contact PI
Project 5$384,994
P50 · FY2015 · DE · contact PI
Effect of HIV and immunosuppression on oral HPV persistence in the HAART era$181,551
R56 · FY2015 · DE · contact PI
Effect of HIV and immunosuppression on oral HPV persistence in the HAART era$839,140
R01 · FY2014 · DE · contact PI
Project 5$382,998
P50 · FY2014 · DE · contact PI
Effect of HIV and immunosuppression on oral HPV persistence in the HAART era$955,353
R01 · FY2013 · DE · contact PI
Project 5$395,828
P50 · FY2013 · DE · contact PI
Effect of HIV and immunosuppression on oral HPV persistence in the HAART era$734,535
R01 · FY2012 · DE · contact PI
Effect of HIV and immunosuppression on oral HPV persistence in the HAART era$331,800
R01 · FY2012 · DE · contact PI
Project 5$318,707
P50 · FY2012 · DE · contact PI
Effect of HIV and immunosuppression on oral HPV persistence in the HAART era$753,514
R01 · FY2011 · DE · contact PI
Effect of HIV and immunosuppression on oral HPV persistence in the HAART era$652,003
R01 · FY2010 · DE · contact PI